| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |